abstract |
The present invention relates to pyrrolidine-2-carboxamide derivatives of formula (I), wherein R 1 , R 2 , R 3 , R 3 , R 4 , R 5 are as described herein and which act as antagonists of mdm2 interactions and hence are useful as potent and selective anticancer agents. |